跳至主要内容
临床试验/NCT05060289
NCT05060289招募中不适用

A Prognostic Model for Drug-induced Liver Injury in China : A Multi-center, Prospective Cohort Study

Beijing Friendship Hospital13 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2022年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
3,000
试验地点
13
主要终点
acute liver failure

研究概览

简要总结

A prospective, multi-center, non-interventional cohort study is going to conduct to explore the clinical characteristics, culprit drug(s) or herb(s), outcomes and risk factors of Drug-induced liver injury (DILI) in China and screen novel serum markers.

A prognostic model incorporating with the novel serum marker(s) for DILI would be established and validated to imporve the prognosis of patients in China .

详细描述

Research Objectives:

  1. To establish a standardized multi-center, prospective DILI cohort nationwide and obtain long-term prognostic data.
  2. To establish and verify prognostic model(s) of DILI in China.
  3. To explore novel serum biomarkers for the prognosis of DILI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • RUCAM ≥6 and met one of the following biochemical conditions: (1) ALT≥5 ULN, (2) or ALP ≥2 ULN, (3) or ALT≥3 ULN and TBil≥2 ULN.
  • RUCAM between 3-5, five experienced hepatologists in leading site evaluate and vote the diagnosis of DILI, the case would be enrolled if only ≥4 out of 5 hepatologists agree with the diagnosis.
  • Onset to enrollment ≤3 months.

排除标准

  • Hepatotropic viral infection: hepatitis A, B, C, D and E.
  • Non-hepatotropic viral infection: cytomegalovirus (CMV) and Epstein-Barr virus (EBV), etc.
  • Hypoxic ischemic hepatitis and congestive liver disease.
  • Alcohol consumption: male >40g/d, female >20g/d, and ≥5 years.
  • Biliary obstruction, primary biliary cholangitis; primary sclerosing cholangitis.
  • Autoimmune hepatitis: International Autoimmune Hepatitis Group (IAHG) simplified score ≥6 or complicated score ≥10, or differentiation from autoimmune hepatitis is impossible during enrollment.
  • Parasitic infection.
  • Previous liver transplantation or bone marrow transplantation.
  • Pregnancy or lactation.
  • Genetic and metabolic liver diseases.

结局指标

主要结局

acute liver failure

时间窗: 1 year

Acute liver failure is defined as elevated bilirubin and prolonged international normalized ratio (INR) ≥1.5 accompanied by mental disturbance within 26 weeks after DILI onset without underlying chronic liver diseases.

death/liver transplantation

时间窗: 1 year

DILI has a primary, contributory role for the death (liver-related mortality) or no role for the death (all-cause mortality) . DILI is the primary indication for liver transplantation.

次要结局

  • chronic DILI(2 years)
  • recovery(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhao Xinyan

Professor

Beijing Friendship Hospital

研究点 (13)

Loading locations...

相似试验

A Prognostic Model for Drug-induced Liver Injury in... | 临床试验